Journal of Neuroimmunology
Volume 215, Issue 1 , Pages 36-42 , 30 October 2009

LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R)

  • Laura Maggi

      Affiliations

    • Istituto Pasteur-Fondazione Cenci Bolognetti & Dipartimento di Fisiologia e Farmacologia, Centro di Eccellenza BEMM, Università di Roma “Sapienza”, Piazzale A. Moro 5, I00185 Roma, Italy
    • ,
  • Flavia Trettel

      Affiliations

    • Istituto Pasteur-Fondazione Cenci Bolognetti & Dipartimento di Fisiologia e Farmacologia, Centro di Eccellenza BEMM, Università di Roma “Sapienza”, Piazzale A. Moro 5, I00185 Roma, Italy
    • ,
  • Maria Scianni

      Affiliations

    • Istituto Pasteur-Fondazione Cenci Bolognetti & Dipartimento di Fisiologia e Farmacologia, Centro di Eccellenza BEMM, Università di Roma “Sapienza”, Piazzale A. Moro 5, I00185 Roma, Italy
    • ,
  • Cristina Bertollini

      Affiliations

    • Istituto Pasteur-Fondazione Cenci Bolognetti & Dipartimento di Fisiologia e Farmacologia, Centro di Eccellenza BEMM, Università di Roma “Sapienza”, Piazzale A. Moro 5, I00185 Roma, Italy
    • ,
  • Fabrizio Eusebi

      Affiliations

    • Istituto Pasteur-Fondazione Cenci Bolognetti & Dipartimento di Fisiologia e Farmacologia, Centro di Eccellenza BEMM, Università di Roma “Sapienza”, Piazzale A. Moro 5, I00185 Roma, Italy
    • Neuromed I.R.C.C.S., Via Atinese 18, I-86077 Pozzilli, Italy
    • ,
  • Bertil B. Fredholm

      Affiliations

    • Department of Physiology and Pharmacology, Karolinska Institutet, S-171 77 Stockolm, Sweden.
    • ,
  • Cristina Limatola

      Affiliations

    • Istituto Pasteur-Fondazione Cenci Bolognetti & Dipartimento di Fisiologia e Farmacologia, Centro di Eccellenza BEMM, Università di Roma “Sapienza”, Piazzale A. Moro 5, I00185 Roma, Italy
    • Neuromed I.R.C.C.S., Via Atinese 18, I-86077 Pozzilli, Italy
    • Corresponding Author InformationCorresponding author. Istituto Fisiologia Umana P.le A. Moro 5, 00185 Rome, Italy. Tel.: +39 06 49690243; fax: +39 06 49910851.

Received 2 April 2009 ,Revised 29 July 2009 ,Accepted 29 July 2009.

References 

  1. Asensio VC, Campbell IL. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 1999;22:504–512
  2. Bertollini C, Ragozzino D, Gross C, Limatola C, Eusebi F. Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacology. 2006;51:816–821
  3. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, et al. CXCR4-activated astrocyte glutamate release via TNF: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 2001;4:702–710
  4. Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 1973;232:331–356
  5. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361:31–39
  6. Boulanger LM, Huh GS, Shatz CJ. Neuronal plasticity and cellular immunity: shared molecular mechanisms. Curr. Opin. Neurobiol. 2001;11:568–578
  7. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006;9:917–924
  8. Chapman GA, Moores K, Harrison D, Campbell CA, Steward BR, Strijbos PJLM. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 2000;20:RC87
  9. Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, et al. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 1999;19:9192–9200
  10. Chun J. Selected comparison of immune and nervous system development. Adv. Immunol. 2001;77:297–322
  11. Costenla AR, Lopes LV, de Mendonça A, Ribeiro JA. A functional role for adenosine A3 receptors: modulation of synaptic plasticity in the rat hippocampus. Neurosci. Lett. 2001;302:53–57
  12. Cunha RA. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 2001;38:107–125
  13. Cunningham AJ, Murray CA, O'Neill LA, Lynch MA, O'Connor JJ. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 1996;203:17–20
  14. Curran B, O'Connor JJ. The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience. 2001;108:83–90
  15. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 2001;24:31–55
  16. Dunwiddie TV, Diao L, Kim HO, Jiang JL, Jacobson KA. Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J. Neurosci. 1997;17:607–614
  17. Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 2007;14:1315–1323
  18. Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM. Adenosine and brain function. Int. Rev. Neurobiol. 2005;63:191–270
  19. Fujii S. ATP- and adenosine-mediated signaling in the central nervous system: the role of extracellular ATP in hippocampal long-term potentiation. J. Pharmacol. Sci. 2004;94:103–106
  20. Gillard SE, Lu M, Mastracci RM, Miller RJ. Expression of functional chemokine receptors by rat cerebellar neurons. J. Neuroimmunol. 2002;124:16–28
  21. Giménez-Llort L, Masino SA, Diao L, Fernández-Teruel A, Tobeña A, Halldner L, et al. Mice lacking the adenosine A1 receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly. Synapse. 2005;57:8–16
  22. Giovannelli A, Limatola C, Ragozzino D, Mileo AM, Ruggieri A, Ciotti MT, et al. CXC chemokines interleukin-8 (IL-8) and growth-related gene product (GRO) modulate Purkinje neuron activity in mouse cerebellum. J. Neuroimmunol. 1998;92:122–132
  23. Griffin R, Nally R, Nolan Y, McCartney Y, Linden J, Lynch M. The age-related attenuation in long-term potentiation is associated with microglial activation. J. Neurochem. 2006;99:1263–1272
  24. Hammarberg C, Schulte G, Fredholm BB. Evidence for functional adenosine A3 receptors in microglia cells. J. Neurochem. 2003;86:1051–1054
  25. Håkansson K, Galdi S, Hendrick J, Snyder G, Greengard P, Fisone G. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. J. Neurochem. 2006;96:482–488
  26. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA. 1998;95:10896–10901
  27. Hatori K, Nagai A, Heisel R, Ryu JK, Kim SU. Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res. 2002;69:418–426
  28. Hauss-Wegrzyniak B, Lynch MA, Vraniak PD, Wenk GL. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp. Neurol. 2002;176:336–341
  29. Hughes PM, Botham MS, Frentzel S, Mir A, Perry VH. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia. 2002;37:314–327
  30. Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Gimenez-Llort L, et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. USA. 2001;98:9407–9412
  31. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 2000;20:4106–4114
  32. Kessey K, Trommer BL, Overstreet LS, Ji T, Mogul DJ. A role for adenosine A2 receptors in the induction of long-term potentiation in the CA1 region of rat hippocampus. Brain Res. 1997;756:184–190
  33. Lauro C, Di Angelantonio S, Cipriani R, Sobrero F, Antonilli L, Brusadin V, et al. Activity of adenosine receptors type 1 is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J. Immunol. 2008;80:7590–7596
  34. Lax P, Limatola C, Fucile S, Trettel F, Di Bartolomeo S, Renzi M, et al. Chemokine receptor CXCR2 regulates the functional properties of AMPA-type glutamate receptor GluR1 in HEK cells. J. Neuroimmunol. 2002;129:66–73
  35. Limatola C, Giovannelli A, Maggi L, Ragozzino D, Castellani L, Ciotti MT, et al. SDF-1-mediated modulation of synaptic transmission in rat cerebellum. Eur. J. Neurosci. 2000;12:2497–2504
  36. Limatola C, Lauro C, Catalano M, Ciotti MT, Bertollini C, Di Angelantonio S, et al. Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J. Neuroimmunol. 2005;166:19–28
  37. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA. 1998;95:14500–14505
  38. Meucci O, Fatatis A, Simen AA, Miller RJ. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA. 2000;97:8075–8080
  39. Oh SB, Endoh T, Simen AA, Ren D, Miller RJ. Regulation of calcium currents by chemokines and their receptors. J. Neuroimmunol. 2002;123:66–75
  40. Ragozzino D, Renzi M, Giovannelli A, Eusebi F. Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum. J. Neuroimmunol. 2002;127:30–36
  41. Ragozzino D, Di Angelantonio S, Trettel F, Bertollini C, Maggi L, Gross C, et al. Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J. Neurosci. 2006;26:10488–10498
  42. Salvatore CA, Tilley SL, Latour AM, Fletcher DS, Koller BH, Jacobson MA. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J. Biol. Chem. 2000;275:4429–4434
  43. Tran PB, Miller RJ. Chemokine receptors: signposts to brain development and disease. Nat. Rev., Neurosci. 2003;4:444–455
  44. Tsien JZ, Huerta PT, Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell. 1996;87:1327–1338
  45. Winder DG, Sweatt JD. Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat. Rev., Neurosci. 2001;2:461–474
  46. Woo NH, Abel T, Nguyen PV. Genetic and pharmacological demonstration of a role for cyclic AMP-dependent protein kinase-mediated suppression of protein phosphatases in gating the expression of late LTP. Eur. J. Neurosci. 2002;16:1871–1876
  47. Woo NH, Duffy SN, Abel T, Nguyen PV. Temporal spacing of synaptic stimulation critically modulates the dependence of LTP on cyclic AMP-dependent protein kinase. Hippocampus. 2003;13:293–300
  48. Zujovic V, Benavides J, Vigé X, Carter C, Taupin V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia. 2000;29:305–315

PII: S0165-5728(09)00300-2

doi: 10.1016/j.jneuroim.2009.07.016

Journal of Neuroimmunology
Volume 215, Issue 1 , Pages 36-42 , 30 October 2009

Article Tools

* Image Usage & Resolution